TCL Archive “The One Thing You Want From AN NCI Director: He Will Be Bound By The Facts” October 28, 1994
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive In Brief: Hellman To Head DCT board; Gard Joins Colorado Group; NCI May Support Death Index September 12, 1980